The value of CA19-9 dynamics in decision making for treatment of locally advanced pancreatic cancer

Gland Surg. 2024 Mar 27;13(3):458-460. doi: 10.21037/gs-23-477. Epub 2024 Mar 21.

Authors

Ingmar F Rompen¹, Joseph R Habib¹, Elisabetta Sereni¹, Ammar A Javed¹

Affiliation

¹ Department of Surgery, The NYU Grossman School of Medicine and NYU Langone Health, New York, NY, USA.

No abstract available

Keywords: Carbohydrate antigen 19-9 (CA19-9); locally advanced pancreatic cancer (LAPC); pancreatic neoplasms.

Publication types

Editorial
Comment